Trial
NCT00881114
Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Georgetown University
Collaborators
—
Condition
Head and Neck Cancer
Intervention
Cisplatin
Why stopped
Investigator decided it was not feasible to conduct this study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-03-27